000 01642 a2200469 4500
005 20250516155655.0
264 0 _c20140818
008 201408s 0 0 eng d
022 _a1549-9642
024 7 _a10.1016/j.nano.2013.06.010
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMunger, Mark A
245 0 0 _aIn vivo human time-exposure study of orally dosed commercial silver nanoparticles.
_h[electronic resource]
260 _bNanomedicine : nanotechnology, biology, and medicine
_cJan 2014
300 _a1-9 p.
_bdigital
500 _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aBlood Cell Count
650 0 4 _aFemale
650 0 4 _aHeart
_xdiagnostic imaging
650 0 4 _aHumans
650 0 4 _aLung
_xdiagnostic imaging
650 0 4 _aMagnetic Resonance Imaging
650 0 4 _aMale
650 0 4 _aMetal Nanoparticles
_xadministration & dosage
650 0 4 _aMiddle Aged
650 0 4 _aRadiography, Thoracic
650 0 4 _aReactive Oxygen Species
_xmetabolism
650 0 4 _aSilver
_xadministration & dosage
650 0 4 _aSputum
_xmetabolism
650 0 4 _aUrinalysis
700 1 _aRadwanski, Przemyslaw
700 1 _aHadlock, Greg C
700 1 _aStoddard, Greg
700 1 _aShaaban, Akram
700 1 _aFalconer, Jonathan
700 1 _aGrainger, David W
700 1 _aDeering-Rice, Cassandra E
773 0 _tNanomedicine : nanotechnology, biology, and medicine
_gvol. 10
_gno. 1
_gp. 1-9
856 4 0 _uhttps://doi.org/10.1016/j.nano.2013.06.010
_zAvailable from publisher's website
999 _c22876836
_d22876836